{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:35:10Z","timestamp":1790757310537,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cld.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:34:57Z","timestamp":1666067697000},"page":"57-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Renal Insufficiency in Patients with Cirrhosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Caroline L.","family":"Matchett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Simonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib1","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib4","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: Problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib6","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib7","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"Summary of recommendation Statements","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"2 Suppl 1","key":"10.1016\/j.cld.2022.08.010_bib11","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.cld.2022.08.010_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrgastro.2015.174","article-title":"The evolving concept of acute kidney injury in patients with cirrhosis","volume":"12","author":"Wong","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.08.010_bib14","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.cld.2022.08.010_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/apt.12891","article-title":"Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality","volume":"40","author":"Jang","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cgh.2019.09.035","article-title":"Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure","volume":"18","author":"Piano","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib17","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/hep.30499","article-title":"Cholemic nephropathy causes acute kidney injury and is Accompanied by loss of Aquaporin 2 in Collecting Ducts","volume":"69","author":"Br\u00e4sen","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib18","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","article-title":"Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial","volume":"12","author":"Umgelter","year":"2008","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2022.08.010_bib20","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/CCLM.2011.156","article-title":"Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia","volume":"49","author":"Decavele","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2013.05.014","article-title":"Urinary interleukin 18 for Detection of acute kidney injury: a meta-analysis","volume":"62","author":"Liu","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib25","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cld.2022.08.010_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2022.08.010_bib28","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/liv.13738","article-title":"Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A\u00a0randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","article-title":"Albumin selectively inhibits TNF\u03b1-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells","volume":"55","author":"Zhang","year":"2002","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis Delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2022.08.010_bib36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000940","article-title":"Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Kamal","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2022.08.010_bib40","first-page":"1","article-title":"In\u00a0vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V(1) and V(2)","volume":"10","author":"Jamil","year":"2017","journal-title":"J\u00a0Exp Pharmacol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.08.010_bib42","first-page":"39","article-title":"A\u00a0randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design","volume":"4","author":"Boyer","year":"2012","journal-title":"Open Access J Clin Trials"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib43","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2021.08.016","article-title":"Terlipressin and the treatment of hepatorenal syndrome: How the CONFIRM trial Moves the story Forward","volume":"79","author":"Belcher","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.cld.2022.08.010_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib46","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2022.08.010_bib48","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib50","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an \u03b1-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib51","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.cld.2022.08.010_bib55","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","article-title":"Antioxidant activity of albumin-bound bilirubin","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc Natl Acad Sci"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2022.08.010_bib56","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/ajrccm.162.4.9910106","article-title":"Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation","volume":"162","author":"Cantin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.08.010_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2022.08.010_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcrc.2015.05.006","article-title":"Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin","volume":"30","author":"Zhang","year":"2015","journal-title":"J\u00a0Crit Care"},{"issue":"10","key":"10.1016\/j.cld.2022.08.010_bib60","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s10620-018-5170-9","article-title":"Chances of renal recovery or liver transplantation after Hospitalization for alcoholic liver disease requiring dialysis","volume":"63","author":"Lenhart","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10620-021-06864-z","article-title":"Renal replacement therapy for acute kidney injury in severe alcohol-associated hepatitis as a bridge to transplant or recovery","volume":"67","author":"Jones","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cld.2022.08.010_bib62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.010_bib63","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2022.08.010_bib64","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.12257","article-title":"Predicting end-stage renal disease after liver transplant","volume":"13","author":"Israni","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.cld.2022.08.010_bib65","unstructured":"Organ Procurement and Transplantation Network. Policies. 2022. Available at: https:\/\/optn.transplant.hrsa.gov\/media\/eavh5bf3\/optn_policies.pdf"},{"issue":"1","key":"10.1016\/j.cld.2022.08.010_bib66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.109.133926","article-title":"Unveiling the vasodilatory actions and mechanisms of relaxin","volume":"56","author":"Conrad","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib67","doi-asserted-by":"crossref","first-page":"e1002248","DOI":"10.1371\/journal.pmed.1002248","article-title":"Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial","volume":"14","author":"Snowdon","year":"2017","journal-title":"Plos Med"},{"issue":"2","key":"10.1016\/j.cld.2022.08.010_bib68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5604\/01.3001.0010.8661","article-title":"Treatment of type-1 hepatorenal syndrome with Pentoxifylline: a randomized placebo controlled clinical trial","volume":"17","author":"Stine","year":"2018","journal-title":"Ann Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:52Z","timestamp":1761069592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1089326122000745"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.010","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Insufficiency in Patients with Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}